Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo B Mansur

Showing results (11-20 of 256) with videos related to

Pageof 26
Sort By:
CNS Spectrums|November 19, 2013
A review of FDA-approved treatment options in bipolar depressionRoger S McIntyre, Danielle S Cha, Rachael D Kim, et al.
Advances in Therapy|November 7, 2013
Obesity and bipolar disorder: synergistic neurotoxic effects?Celina S Liu, André F Carvalho, Rodrigo B Mansur, et al.
Expert Opinion on Pharmacotherapy|March 22, 2023
An update on potential pharmacotherapies for cognitive impairment in bipolar disorderDanica E Johnson, Roger S McIntyre, Rodrigo B Mansur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 26, 2012
Selfish brain and neuroprogression in bipolar disorderRodrigo B Mansur, Danielle S Cha, Elson Asevedo, et al.
Expert Opinion on Drug Safety|December 13, 2023
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)Roger S McIntyre, Rodrigo B Mansur, Joshua D Rosenblat, et al.
Medical Hypotheses|February 28, 2012
Inflammatory cytokines as an underlying mechanism of the comorbidity between bipolar disorder and migraineElisa Brietzke, Rodrigo B Mansur, Rodrigo Grassi-Oliveira, et al.
Journal of Psychiatric Research|June 3, 2020
Caloric restriction, resting metabolic rate and cognitive performance in Non-obese adults: A post-hoc analysis from CALERIE studyRuth Bartelli Grigolon, Elisa Brietzke, Alisson Paulino Trevizol, et al.
Neuropharmacology|September 21, 2013
Implications of epigenetic modulation for novel treatment approaches in patients with schizophreniaDanielle S Cha, Paul A Kudlow, Anusha Baskaran, et al.
Experimental Neurology|January 30, 2019
Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depressionJulia A Hamer, Daniela Testani, Rodrigo B Mansur, et al.
Bipolar Disorders|August 30, 2019
Parsing metabolic heterogeneity in mood disorders: A hypothesis-driven cluster analysis of glucose and insulin abnormalitiesRodrigo B Mansur, Yena Lee, Mehala Subramaniapillai, et al.
Pageof 26

Showing results (11-20 of 256) with videos related to

Sort By:
Pageof 26
CNS Spectrums|November 19, 2013
A review of FDA-approved treatment options in bipolar depressionRoger S McIntyre, Danielle S Cha, Rachael D Kim, et al.
Advances in Therapy|November 7, 2013
Obesity and bipolar disorder: synergistic neurotoxic effects?Celina S Liu, André F Carvalho, Rodrigo B Mansur, et al.
Expert Opinion on Pharmacotherapy|March 22, 2023
An update on potential pharmacotherapies for cognitive impairment in bipolar disorderDanica E Johnson, Roger S McIntyre, Rodrigo B Mansur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 26, 2012
Selfish brain and neuroprogression in bipolar disorderRodrigo B Mansur, Danielle S Cha, Elson Asevedo, et al.
Expert Opinion on Drug Safety|December 13, 2023
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)Roger S McIntyre, Rodrigo B Mansur, Joshua D Rosenblat, et al.
Medical Hypotheses|February 28, 2012
Inflammatory cytokines as an underlying mechanism of the comorbidity between bipolar disorder and migraineElisa Brietzke, Rodrigo B Mansur, Rodrigo Grassi-Oliveira, et al.
Journal of Psychiatric Research|June 3, 2020
Caloric restriction, resting metabolic rate and cognitive performance in Non-obese adults: A post-hoc analysis from CALERIE studyRuth Bartelli Grigolon, Elisa Brietzke, Alisson Paulino Trevizol, et al.
Neuropharmacology|September 21, 2013
Implications of epigenetic modulation for novel treatment approaches in patients with schizophreniaDanielle S Cha, Paul A Kudlow, Anusha Baskaran, et al.
Experimental Neurology|January 30, 2019
Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depressionJulia A Hamer, Daniela Testani, Rodrigo B Mansur, et al.
Bipolar Disorders|August 30, 2019
Parsing metabolic heterogeneity in mood disorders: A hypothesis-driven cluster analysis of glucose and insulin abnormalitiesRodrigo B Mansur, Yena Lee, Mehala Subramaniapillai, et al.
Pageof 26